First Time Loading...

ESSA Pharma Inc
NASDAQ:EPIX

Watchlist Manager
ESSA Pharma Inc Logo
ESSA Pharma Inc
NASDAQ:EPIX
Watchlist
Price: 6.32 USD -5.95% Market Closed
Updated: Apr 20, 2024

ESSA Pharma Inc
Free Cash Flow

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

ESSA Pharma Inc
Free Cash Flow Peer Comparison

Comparables:
ZYME
FUSN
AUPH
SBFM

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
ESSA Pharma Inc
NASDAQ:EPIX
Free Cash Flow
$-21.6m
CAGR 3-Years
-7%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
Free Cash Flow
$-122.4m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Free Cash Flow
$-85.7m
CAGR 3-Years
-41%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Free Cash Flow
$-34.2m
CAGR 3-Years
24%
CAGR 5-Years
8%
CAGR 10-Years
-22%
Sunshine Biopharma Inc
OTC:SBFM
Free Cash Flow
$-9.6m
CAGR 3-Years
-144%
CAGR 5-Years
-78%
CAGR 10-Years
-33%

See Also

What is ESSA Pharma Inc's Free Cash Flow?
Free Cash Flow
-21.6m USD

Based on the financial report for Dec 31, 2023, ESSA Pharma Inc's Free Cash Flow amounts to -21.6m USD.

What is ESSA Pharma Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-16%

Over the last year, the Free Cash Flow growth was 23%. The average annual Free Cash Flow growth rates for ESSA Pharma Inc have been -7% over the past three years , -16% over the past five years .